▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Plus

Neg

Email

Oceaneering International Q3 20 Earnings Conference Call At 11:00 AM ET

By RTTNews Staff Writer ✉ | Published: 10/29/2020 10:00 AM ET

Oceaneering International Inc. (OII) will host a conference call at 11:00 AM ET on Oct. 29, 2020, to discuss Q3 20 earnings results.

To access the live webcast, log on to www.oceaneering.com

For comments and feedback contact: editorial@rttnews.com

New Drugs Approved In December

New Drugs Approved In December

PDUFA Biotech stocks Chemotherapy COVID19 vaccines heart failure lupus ARS

Biotech Stocks Facing FDA Decision In January 2021

New Drugs Approved In November

New Drugs Approved In November

Latest Updates on COVID-19

Johnson & Johnson Single-dose COVID Vaccine Safe And Effective: FDA

US COVID-19 Hospitalizations Declining At Slower Pace

Pfizer, Moderna To Increase Covid Vaccine Supply

U.S. Life Expectancy Dropped A Full Year, Partially Due To COVID

Rise In New US COVID Deaths, Cases; But Hospitalizations Continue To Fall

Read More

COVID-19: Drugs in Development

RELATED NEWS

Oceaneering International Inc. Q4 adjusted earnings Beat Estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

Walmart Creating Community Events To Administer The COVID-19 Vaccine

Pfizer Says EMA Accepted Marketing Authorization Application For Growth Hormone Somatrogon

Deutsche Telekom Sees Higher Adj. EBITDA AL In FY21 After Strong Q4 Profit

US Property Casualty Insurers Face Record Catastrophic Losses From Texas Weather: Fitch

Health Alert Issued For Whole Foods Market's Beef Meatball Products

Dr. Reddy's Recalls Prescription Drug Blister Packages

Australia Passes Law Requiring Google, Facebook To Pay For News

Regeneron Pharma Stops Placebo Group Enrollment For REGEN-COV On Advice From IDMC

Moderna Q4 Loss Widens

Laureate Education Q4 Reported Profit Gains, Despite Lower Revenue

Medtronic Recalls Unused Valiant Navion Thoracic Stent Graft System

Standard Chartered Stock Down On Q4 Loss, Weak H1 Income View; Resumes Dividend

BLUE To Face FDA Next Month, SNSS Catches Eyes, ADVM On Watch

What Awaits Citius Pharma In 2021?

BD, Scanwell To Develop At-Home Rapid Test For COVID-19 - Quick Facts

Pfizer, Moderna To Increase Covid Vaccine Supply

GSK : Phase 2 Trial Of Otilimab In Hospitalized COVID-19 Patients Did Not Reach Significance

The ODP Corporation Q4 Adjusted Earnings $0.55 Per Share

BCLI Slips On FDA Feedback, OTIC Plunges As Ménière's Disease Trial Fails, CLNN On Watch

Stock Alert: Bayport International Surges Over 200%

FDA Warns 10 Companies For Illegally Selling Dietary Supplements

Johnson & Johnson Single-dose COVID Vaccine Safe And Effective: FDA

FDA Approves AbbVie's Humira For Pediatric Ulcerative Colitis

Regeneron Pharma Stops Placebo Group Enrollment For REGEN-COV On Advice From IDMC

Marathon Oil Corp. Q4 adjusted earnings Beat Estimates

SBA Communications Corporation Q4 adjusted earnings Beat Estimates

Extra Space Storage Inc. Q4 adjusted earnings of $1.48 per share

Heidrick & Struggles Q4 Profit Down

Republic Services Q4 adjusted earnings Beat Estimates

ONEOK Inc. Announces Retreat In Q4 Bottom Line

Cimarex Energy Co. Q4 adjusted earnings Beat Estimates

Amgen Submits SNDA For Otezla For Adults With Mild-To-Moderate Plaque Psoriasis

Principal Financial, Elliott Reach Agreement; Announces Review Of Capital Strategy

M&T Bank To Buy People's United In All-stock Deal Valued At $7.6 Bln - Quick Facts

Sanofi, GSK To Refine Antigen Formulation Of COVID-19 Vaccine Based On Initial Phase 1/2 Study

Kuehne + Nagel To Acquire Apex International